Revvity INC REVVITY ORD SHS
Revvity INC REVVITY ORD SHS/ US7140461093 /
0KHE
|
2024-03-25 3:25:46 PM
|
Chg.
-
|
Volume |
Bid6:00:11 AM |
Ask6:00:11 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
103.3900USD
|
-
|
247
Turnover: 3,101.7000 |
-Bid Size: - |
-Ask Size: - |
12.49 bill.USD |
0.28% |
18.18 |
Business description
Revvity offers products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Management board & Supervisory board
| CEO |
| Dr. Prahlad Singh |
| Management board |
| Max Krakowiak, Yves Dubaquie, Alan Fletcher, Magali Four, Joel Goldberg, Madhuri Hegde, Yi-Ping Lin, Dan Tereau, Jayashree Thacker, Miriame Victor, Tajinder Vohra, Kevin Willoe, Arvind Sundar-Rajan |
| Supervisory board |
| Alexis P. Michas, Peter Barrett, Samuel R. Chapin, Dr. Sylvie Grégoire, Dr. Michelle McMurry-Heath, Dr. Prahlad Singh, Michel Vounatsos, Frank Witney, Pascale Witz |
Company data
| Name: |
Revvity |
| Address: |
940 Winter Street,Waltham, Massachusetts 02451, USA |
| Phone: |
+1-781-663-6900 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.revvity.com |
| Industry: |
Healthcare |
| Sector: |
Healthcare Providers |
| Sub sector: |
Healthcare Providers |
| End of financial year: |
12-31 |
| Free Float: |
60.70% |
| IPO date: |
1960-12-13 |
Investor relations
| Name: |
Steve Willoughby |
| IR phone: |
+1-781-663-5677 |
| IR Fax: |
- |
| IR e-mail: |
ir@revvity.com
|
Company calendar
|
CW 19 | 2024-05-10
Dividend Payment
|
